Gene: ZNF250
Official Full Name: zinc finger protein 250provided by HGNC
Gene Summary: Enables identical protein binding activity and sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30085 | ZNF250 Knockout cell line (HeLa) | Human | ZNF250 | 1:3~1:6 | Negative | Online Inquiry |
KO30086 | ZNF250 Knockout cell line (HCT 116) | Human | ZNF250 | 1:2~1:4 | Negative | Online Inquiry |
KO30087 | ZNF250 Knockout cell line (HEK293) | Human | ZNF250 | 1:3~1:6 | Negative | Online Inquiry |
KO30088 | ZNF250 Knockout cell line (A549) | Human | ZNF250 | 1:3~1:4 | Negative | Online Inquiry |
ZNF250 Gene Knockout Cell Lines represent a cutting-edge tool in the study of gene function and regulation in mammalian cells. These cell lines are engineered to have a targeted disruption of the ZNF250 gene, a crucial component often involved in various cellular processes including transcriptional regulation, cell differentiation, and signal transduction. By knocking out this specific gene, researchers can elucidate its role in normal physiology and disease pathology, providing a clearer understanding of its functional mechanisms.
The ZNF250 knockout leads to observable changes in gene expression profiles and cellular behavior, which can be tracked through various molecular techniques including qPCR, western blotting, and flow cytometry. The specific knockout mechanisms employed involve CRISPR-Cas9 technology, which allows for precise edits in the genome, facilitating the study of loss-of-function phenotypes. This precision not only ensures reproducibility but also enables researchers to dissect complex biological networks more effectively.
In terms of scientific importance, ZNF250 Gene Knockout Cell Lines serve as invaluable models in research addressing cancers, developmental biology, and metabolic disorders. By studying these alterations, scientists can develop targeted therapeutics. In clinical settings, insights garnered from these models can lead to tailored treatment strategies, enhancing patient outcomes.
The advantages of ZNF250 Gene Knockout Cell Lines are significant. Unlike traditional knockout methodologies, our advanced CRISPR-Cas9 approach minimizes off-target effects while maximizing efficiency, providing a more robust platform for experimental validation. Additionally, these cell lines are readily available and well-characterized, saving researchers invaluable time and resources.
By opting for ZNF250 Gene Knockout Cell Lines, researchers and clinicians access a powerful resource that unlocks potential pathways for discovery and innovation. Their precise engineering, combined with their applicability across multiple biological contexts, makes them an essential addition to any laboratory focused on genetic research. Our company, with its commitment to advancing the frontiers of molecular biology, offers these products alongside detailed technical support and expertise, ensuring that users achieve their research goals effectively and efficiently.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.